SynthesisBritish journal of cancer2024

Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer.

Hajime Kamiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.